Presented By: Dylan McKenny, MD
Friday, March 29, 2024
11:00 AM – 3:30 PM EDT
The training is composed of two experiential sessions, three lectures, and discussion sessions throughout (verbally or via chat). The first lecture provides an overview of the field of psychedelic medicine, focusing on the clinical uses of Ketamine, MDMA, and psilocybin. The second lecture offers a description of the practice of psychedelic assisted psychotherapy with particular focus on MDMA assisted therapy for PTSD. The final lecture covers ethical considerations unique to these emerging treatments. Experiential sessions will include a breath work session and a simulation of a psychedelic dosing session.
This training is worth four (4) continuing education hours.
An application for four (4) continuing education hours has been made to the Maine Board of Alcohol and Drug Counselors.
Agenda for the Day:
11:00am – Presentation: Overview of Psychedelic Medicine
11:50am – Discussion
12:05pm – Break
12:10pm – Experiential Session
12:30pm – Presentation: Psychedelic Assisted Psychotherapy
1:15pm – Discussion
1:30pm – Break
1:40pm – Experiential Session
2:00pm – Presentation: Ethics in Psychedelic Treatment
2:45pm – 3:30pm – Open discussion and wrap-up
About the presenter:
Dylan McKenney MD studied Medicine at the University of Vermont Larner College of Medicine. From 2009-2014 he trained as a resident physician in Psychiatry, then completed a Child and Adolescent Psychiatry fellowship at Maine Medical Center. He is certified by the American Board of Psychiatry and Neurology in Adult, Child, and Adolescent Psychiatry. Dr. McKenney practiced in a hospital setting for nearly ten years before starting a private practice in Portland where he currently treats patients of all ages. He also practices at Boston Child Study Center in Portland, Maine where he is beginning to conduct research using ketamine to treat mental health conditions.
Dr. McKenney is a candidate for certification at the California Institute of Integral Studies, Psychedelic-Assisted Therapies and Research program. He has experience in ketamine treatment modalities including ketamine-assisted psychotherapy. He has completed MAPS training in MDMA-assisted psychotherapy and is passionate about the emerging field of psychedelic psychiatry.
Sign Up To Receive Our Latest Blog Posts!
Learn more tips on living well and understanding mental illness. Help to end the stigma, and hear inspiring stories of recovery. Sign up here!